Search for: "Bayer v. Bayer" Results 841 - 860 of 1,122
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Aug 2010, 8:44 pm by Marie Louise
  Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging… [read post]
9 Aug 2010, 10:14 pm
Bayer Bioscience N.V., 514 F.3d 1229, 1239-40 (Fed. [read post]
4 Aug 2010, 12:21 am by Kelly
(Patent Docs) Gemzar (Gemcitabine) – US: CAFC affirms invalidity of Lilly’s Gemzar patent for obviousness-type double patenting: Sun Pharmaceuticals v. [read post]
28 Jul 2010, 12:06 am by Kelly
(Patent Docs) Levitra (Vardenafil) – US: Patent infringement complaint following a Paragraph IV certification: Bayer Schering Pharma AG et al. v. [read post]
15 Jul 2010, 2:28 am by war
Wright Rubber Products Pty Ltd v Bayer AG [2010] FCAFC 85 [read post]
7 Jul 2010, 5:14 am
Siemens (EPLAW) India: Novartis & Bayer appeals to be heard by the Supreme Court in the next 30 days (Spicy IP) US: House passes patent settlement legislation as part of the War Funding Bill (FDA Law Blog) US: Bilski v Kappos: What effects on biotechnology patents? [read post]
6 Jul 2010, 6:03 pm by Duncan
Siemens (EPLAW) India: Novartis & Bayer appeals to be heard by the Supreme Court in the next 30 days (Spicy IP) US: House passes patent settlement legislation as part of the War Funding Bill (FDA Law Blog) US: Bilski v Kappos: What effects on biotechnology patents? [read post]
23 Jun 2010, 10:28 pm
Bayer CropScience AG- Can a supplementary protection certificate based on a provisional marketing authorisation be granted? [read post]
16 Jun 2010, 3:02 pm
Novartis Animal Health US, Inc (Docket Report) US: Finding ORGANIC ASPIRIN deceptively misdescriptive of and deceptive for dietary supplements, TTAB sustains Bayer opposition: Bayer Aktiengesellschaft v. [read post]
8 Jun 2010, 2:29 pm
Bayer AG, Bayer Corp., Civ. [read post]